BENEFIT IN CENTRAL HAEMODYNAMIC PARAMETERS BY ASSOCIATION ANGIOTENSIN II RECEPTOR BLOCKERS AND CANRENONE THERAPY IN HYPERTENSIVE PATIENTS WITH NORMAL KIDNEY FUNCTION

被引:0
|
作者
Paterno, C. [1 ]
Mastrorocco, N. [2 ]
Goffredo, I. [2 ]
机构
[1] Cardiovasc Res Ctr, Foggia, Italy
[2] Pugliese Inst Social & Econ Res, Bari, Italy
关键词
D O I
10.1097/01.hjh.0000491883.86770.fb
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
PP.13.11
引用
收藏
页码:E194 / E194
页数:1
相关论文
共 50 条
  • [41] Incidence and Pattern of Aminotransferase Elevation During Anti-Hypertensive Therapy With Angiotensin-II Receptor Blockers
    Choi, Won Joon
    Kim, Gi-Ae
    Park, Jaewon
    Jang, Sangmi
    Jung, Woo Jin
    Shim, Jae-Jun
    Park, Yewan
    Choi, Gwang Hyeon
    Kim, Jin-Wook
    Jeong, Sook-Hyang
    Jang, Eun Sun
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2022, 37 (33)
  • [42] Efficacy and safety of two dosages of canrenone as add-on therapy in hypertensive patients taking ace-inhibitors or angiotensin II receptor blockers and hydrochlorothiazide at maximum dosage in a randomized clinical trial: The ESCAPE-IT trial
    Derosa, Giuseppe
    Maffioli, Pamela
    D'Avino, Maria
    Sala, Carla
    Mugellini, Amedeo
    Vulpis, Vito
    Felis, Salvatore
    Guasti, Luigina
    Sarzani, Riccardo
    Bestetti, Alessandro
    Vanasia, Massimo
    Gaudio, Giovanni
    CARDIOVASCULAR THERAPEUTICS, 2017, 35 (01) : 47 - 54
  • [43] Type 1 angiotensin II receptor subtypes in kidney of normal and salt-sensitive hypertensive rats
    Bouby, N
    Bankir, L
    LlorensCortes, C
    HYPERTENSION, 1996, 27 (03) : 392 - 398
  • [44] Angiotensin-converting enzyme inhibitors are comparable to angiotensin II receptor blockers in the primary prevention of myocardial infarction in hypertensive patients
    Baer, JT
    Sauer, WH
    Berlin, JA
    Kimmel, SE
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 531A - 531A
  • [45] Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and prognosis of hypertensive patients hospitalised with COVID-19
    Covino, Marcello
    De Matteis, Giuseppe
    Burzo, Maria Livia
    Santoro, Michele
    Fuorlo, Mariella
    Sabia, Luca
    Sandroni, Claudio
    Gasbarrini, Antonio
    Franceschi, Francesco
    Gambassi, Giovanni
    INTERNAL MEDICINE JOURNAL, 2020, 50 (12) : 1483 - 1491
  • [46] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients
    Zhang, Ling
    Zeng, Xiaoxi
    Fu, Ping
    Wu, Hong Mei
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (06):
  • [47] Angiotensin II receptor blockers and bone fracture in chronic kidney disease patients: the Fukuoka kidney disease Registry Study
    Shukuri, Tomoya
    Nakai, Kentaro
    Tanaka, Shigeru
    Yamada, Shunsuke
    Tokumoto, Masanori
    Tsuruya, Kazuhiko
    Nakano, Toshiaki
    Kitazono, Takanari
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2023, 27 (11) : 919 - 927
  • [48] Angiotensin II receptor blockers and bone fracture in chronic kidney disease patients: the Fukuoka kidney disease Registry Study
    Tomoya Shukuri
    Kentaro Nakai
    Shigeru Tanaka
    Shunsuke Yamada
    Masanori Tokumoto
    Kazuhiko Tsuruya
    Toshiaki Nakano
    Takanari Kitazono
    Clinical and Experimental Nephrology, 2023, 27 : 919 - 927
  • [49] Cost-benefit effectiveness of angiotensin-II receptor blockers in patients with uncomplicated hypertension: A comparative analysis
    Mazza, Alberto
    Sacco, Antonella Paola
    Townsend, Danyelle M.
    Bregola, Gianni
    Contatto, Edgardo
    Cappello, Isabella
    Schiavon, Laura
    Ramazzina, Emilio
    Rubello, Domenico
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 90 : 665 - 669
  • [50] Previous use of angiotensin-II receptor blockers in hospitalized hypertensive patients and COVID-19 mortality
    Oscanoa, Teodoro J.
    Amado-Tineo, Jose
    Matta-Perez, Javier
    Taype-Huamani, Waldo
    REVISTA DEL CUERPO MEDICO DEL HOSPITAL NACIONAL ALMANZOR AGUINAGA ASENJO, 2022, 15 (03):